Atossa Therapeutics, Inc.ATOSNASDAQ

Revenue (LTM)

Net Income (LTM)

$-26M

+15.3% YoY

Free Cash Flow

$-21M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	-0↑50.6%	-0↑65.2%	-0↓187.5%	-0↑26.1%
Operating Income	-15	-21↓40.5%	-28↓34.9%	-31↓13.3%	-28↑12.0%
Net Income	-18	-21↓15.6%	-27↓30.8%	-30↓11.6%	-26↑15.3%
EBITDA	-15	-20↓40.8%	-28↓35.1%	-31↓13.3%	-28↑12.0%
EPS Diluted	-29.55	-2.70↑90.9%	-3.15↓16.7%	-3.60↓14.3%	-3.00↑16.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	40	136↑243.8%	111↓18.7%	88↓20.2%	71↓19.6%
Total Current Assets	43	141↑230.2%	118↓16.3%	92↓22.0%	74↓19.3%
Total Assets	43	141↑229.7%	124↓12.6%	96↓22.1%	76↓20.6%
Total Current Liabilities	16	3↓80.1%	6↑78.1%	5↓6.0%	5↓5.1%
Total Liabilities	16	3↓80.1%	6↑78.1%	5↓6.0%	5↓5.1%
Total Equity	27	138↑408.5%	118↓14.6%	91↓22.8%	71↓21.5%
Total Debt	0	0	0	0	0
Net Debt	-40	-136↓244.0%	-111↑18.7%	-88↑20.2%	-71↑19.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-12	-16↓42.4%	-21↓26.0%	-21↓0.9%	-21↓0.4%
Capital Expenditure	-0	-0↑3.9%	-0↓200.0%	-0↑48.1%	-0↓35.7%
Free Cash Flow	-12	-16↓42.3%	-21↓26.1%	-21↓0.8%	-21↓0.4%
Stock-Based Comp	3	5↑74.5%	7↑28.9%	5↓31.9%	2↓50.4%
Net Change in Cash	27	97↑259.0%	-25↓126.3%	-22↑12.0%	-17↑22.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance